Reimbursement of Medical Expenses. The Company shall reimburse the Executive for the full amount of any medical, dental and optical expenses not covered under any group medical plan from time to time in effect for the benefit of Company employees generally. Such coverage shall include without limitation mental health care and treatment and other medical, dental and optical expenses not covered under the Company's health care plan now or hereafter in effect. The Company may satisfy its obligation to the Executive under this Section 5.7 by providing excess medical, dental, optical and other health care insurance coverage for the Executive's benefit.
Reimbursement of Medical Expenses. I recognize and acknowledge there is no volunteer accident coverage nor is there any medical payments coverage available to me in order to compensate me for expenses I incur from deductibles, co-payments, prescription drugs, or medical services not covered through my own health insurance provider(s) for any injury I sustain as a result of performing my services. I agree that any medical coverage(s) I have will be primary and under no circumstance will I seek any contribution from the Diocese, or their insurer, for any medical expenses.
Reimbursement of Medical Expenses. Institution will offer or will coordinate medical care to Subjects who suffer an adverse reaction, illness, or injury during a Study. For each Study, SPONSOR will reimburse Institution or other medical provider at rates that constitute fair market value for industry sponsored studies, for the reasonable and necessary, actually incurred costs of providing such medical diagnosis and treatment of any adverse reaction, illness or injury directly arising from the use of the applicable Study Device(s) in accordance with the applicable Protocol or procedures that the Subject would not have undergone but for participation in the Study. Notwithstanding the foregoing, SPONSOR's obligation to reimburse Institution will be reduced to the extent that such adverse reaction, illness or injury is attributable to: (i) the negligence or misconduct of Institution, the applicable Principal Investigator, or their respective employees and agents; (ii) if applicable, a known risk of an FDA approved treatment or device of the type being studied; (iii) failure to adhere to the applicable Protocol (it being understood, however, that emergency medical care shall not be deemed a violation of the Protocol), other non-conflicting written instructions provided by SPONSOR, or Applicable Laws by Institution, the applicable Principal Investigator, or their respective employees and agents; or (iv) the natural progression of a pre-existing medical condition or underlying disease of the Subject. For purposes of this Section causation of adverse reactions, illness and injury, and whether the exception set forth in Section 20.3(iii) applies shall be determined in the reasonable medical judgement of the Principal Investigator after consultation with SPONSOR and good faith consideration of all data presented by SPONSOR related to causation. SPONSOR's agreement to pay Institution under this Section
Reimbursement of Medical Expenses. 13.1 The Company agrees to reimburse all medical expenses incurred by the Executive and his immediate family in the thirty six (36) months prior to April 12, 2006 and during the term of this Agreement that is not covered by the Company’s permanent health insurance scheme.
Reimbursement of Medical Expenses. The Company shall reimburse the Group for the reasonable and necessary medical expenses incurred by a Study Subject or Member Institution for the diagnosis and treatment of any personal injury relating to (a) the administration of the Study Drug substantially in accordance with this Agreement, the Protocol, and any other written instructions of the Company or (b) the performance of any test or procedure that is required by such Protocol to which the Study Subject would not have been exposed but for the Study Subject’s participation in the Study. Notwithstanding the foregoing, the Company shall not be responsible for any portion of such medical expenses that are attributable to the Group’s breach, negligence or willful misconduct.
Reimbursement of Medical Expenses. GLDI shall reimburse the Executive for the full amount of any medical, dental and optical expenses not covered under any group medical plan from time to time in effect for the benefit of Company employees generally. GLDI may satisfy its obligation to the Executive under this Section 5.6 by providing excess medical, dental, optical and other health care insurance coverage for the Executive's benefit.
Reimbursement of Medical Expenses. (a) Notwithstanding Section 19.1, SPONSOR shall reimburse the Institution for the direct, reasonable and necessary medical expenses incurred by the Institution for the treatment of any personal injury that is a direct result of (a) the use of the Study Device in accordance with this Agreement, the Protocol and any other written instructions of SPONSOR or (b) any performance of any test or procedure that is required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study if (i) the Institutional Indemnified Parties have complied with this Agreement, the Protocol and any written instructions of SPONSOR concerning the Study and (ii) all the requirements of informed consent have been complied with in accordance with Section 5.2.; (iii) such injury is not attributable to a pre-existing condition or underlying disease of the subject; or (iv) such injury is not attributable to the negligence or misconduct of the Institutional Indemnified Parties. SPONSOR will not provide compensation for lost wages or for any other damages, expenses or losses, or for medical expenses that have been covered by a Subject’s medical or other insurance, provided, however, SPONSOR understands and agrees that Subject is not required to file an insurance claim.
Reimbursement of Medical Expenses. There is no specified facility of medical reimbursement. However, on application, the Educational Officer may consider the grant of ex- gratia payment on case-to-case basis.
Reimbursement of Medical Expenses. Institution will offer or will coordinate medical care to Subjects who suffer an adverse reaction, illness, or injury during a Trial and two (2) years after the closure of such Trial. For each Trial, SPONSOR will reimburse Institution or other medical provider for the reasonable and necessary, actually incurred costs of providing such medical diagnosis and treatment of any adverse reaction, illness or injury directly arising from
Reimbursement of Medical Expenses. Notwithstanding Section 19.1, AstraZeneca shall reimburse the Institution for the direct, reasonable and necessary medical expenses incurred by the Institution for the treatment of any personal injury that is a direct result of (a) the administration of the Study Drug or of any placebo in accordance with this Agreement, the Protocol and any other written instructions of AstraZeneca or (b) any performance of any test or procedure that is required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study if (i) the Institutional Indemnified Parties have complied with this Agreement, the Protocol and any written instructions of AstraZeneca concerning the Study and (ii) all the requirements of informed consent have been complied with in accordance with Section 5.2. AstraZeneca will not provide compensation for lost wages or for any other damages, expenses or losses, or for medical expenses that have been covered by a Subject’s medical or other insurance, provided, however, AstraZeneca understands and agrees that Subject is not required to file an insurance claim.
